Respective role of haemosiderosis and desferrioxamine therapy in the risk from infection of haemodialysed patients.
Tielemans
C
C
Hôpital Universitaire Brugmann, Free University of Brussels, Belgium.
Lenclud
C
C
D001424:Bacterial Infections / Q000209:etiology* / Q000517:prevention & control; D003676:Deferoxamine / Q000627:therapeutic use*; D006486:Hemosiderosis / Q000150:complications*; D006801:Humans; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors
D003676:Deferoxamine